Organization · Venture Capital
TS Investment
TS Investment is a Seoul-based venture capital firm founded in 2008, focusing on investment management and advisory services for small and medium-sized enterprises in South Korea.
Overview
What TS Investment does
What TS Investment is
TS Investment is a Seoul-based venture capital firm founded in 2008, focusing on investment management and advisory services for small and medium-sized enterprises in South Korea.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2008
- Approximate age
- About 18 years
- Structured capabilities
- Funder
- Last reviewed
- May 1, 2026
Official channels
Find TS Investment elsewhere
Open the official website or a supported primary organization account.
Capability profile
TS Investment as a funder
Investment thesis
TS Investment focuses on investing in small and medium-sized enterprises and venture businesses in Korea, particularly those with promising technologies and innovative business models. The firm is willing to invest from seed through later venture rounds, emphasizing defensible technology and commercialization potential.
Focus narrative
TS Investment actively invests in a range of sectors, including technology, healthcare, travel, and semiconductors. The firm targets Korean startups from seed through Series B/C, providing capital and strategic support to help them grow and succeed in competitive markets.
Value beyond capital
TS Investment adds value to its portfolio companies by providing not only capital but also strategic guidance and access to a network of industry contacts. The firm focuses on helping companies develop defensible technologies and navigate the path to commercialization, IPO, or M&A exits.
Focus and fit
- Stages
- Seed · Series A · Series B · Series C · Growth Equity
- Sectors
- Healthcare · Biotech · Travel · Mobility · Media · SaaS
- Regions
- Asia
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 8
Portfolio context
Notable portfolio companies include: The Hyoosik: Lead investor in a 2025 Series B round. Nex Eye: Participated in an August 2025 Series B round. Illimis Therapeutics: Involved in a July 2025 Series B financing of KRW 58B / $42M for CNS and immune disease drug development. Upvalue: Lead investor in a June 2025 Series A round. Connecteve: Participated in a February 2025 seed round.
Common questions
What to know about TS Investment
Upseed classifies TS Investment under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 1, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.